News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- The Importance of Regulatory Due Diligence During the Acquisition Process
Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
The pandemic exposed significant disparity in the pharmaceutical global supply chain, largely due to the dependency of low- and middle-income countries (LMICs) on pharmaceutical manufacturing in more industrialized nations. To mitigate this inequity and ensure supply of medicinal products across the globe, manufacturing of medicinal products must be decentralized through establishing manufacturing sites in LMICs.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!